ACURA PHARMA
0468.913.836 · rovalta.com · 25/09/2026
ACURA PHARMA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOACURA PHARMA is a Private company with limited liability incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Bruxelles. It employs on average 0,3 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0468.913.836
- Incorporation
- 28/12/1999
- Legal form
- Private company with limited liability
- Registered office
- Rue Drootbeek 91
1020 Bruxelles · BruxellesSee on map - Contributed capital
- 7 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,3 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 139,5 k € | -20.7% | 176 k € | +16.8% | 150,6 k € | -28.4% | 210,5 k € | +237% | 62,5 k € |
| EBITDA | 119,9 k € | -31.7% | 175,6 k € | +16.9% | 150,2 k € | -28.5% | 210,1 k € | +238% | 62,2 k € |
| Operating result | 99,7 k € | -35.6% | 154,8 k € | +19.6% | 129,4 k € | -31.8% | 189,7 k € | +355% | 41,7 k € |
| Net result | 69,8 k € | -37.0% | 110,7 k € | +22.5% | 90,4 k € | -33.3% | 135,5 k € | +426% | 25,8 k € |
| Balance sheet | |||||||||
| Equity | 103,5 k € | +207% | 33,7 k € | +2.2% | 33 k € | +46.2% | 22,6 k € | -80.7% | 117,1 k € |
| Total assets | 366,4 k € | -10.2% | 408,2 k € | -10.5% | 456 k € | -32.1% | 671,5 k € | +10.2% | 609,2 k € |
| Cash | 74,6 k € | +34.3% | 55,5 k € | +3797% | 1,4 k € | -97.2% | 50,7 k € | +56.4% | 32,4 k € |
| Debts | 262,9 k € | -29.8% | 374,5 k € | -11.5% | 423 k € | -34.8% | 648,9 k € | +32.1% | 491,1 k € |
| Other | |||||||||
| Workforce | 0,3 ETP | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/2025Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/07/2026 | 31/07/2025 | 29/07/2024 | 23/06/2023 | 17/06/2022 | 27/07/2021 |
| General meeting | 11/06/2026 | 12/06/2025 | 13/06/2024 | 08/06/2023 | 09/06/2022 | 10/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 11/06/2026 | 31/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 12/06/2025 | 31/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 13/06/2024 | 29/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 08/06/2023 | 23/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 09/06/2022 | 17/06/2022 | Dutch | |
| Micro model | 31/12/2020 | 10/06/2021 | 27/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 11/06/2020 | 30/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 30/06/2019 | 30/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 14/06/2018 | 26/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 08/06/2017 | 15/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 09/06/2016 | 16/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 11/06/2015 | 08/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 12/06/2014 | 18/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 13/06/2013 | 24/06/2013 | Dutch | |
| Abridged model | 31/12/2011 | 21/06/2012 | 28/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 23/06/2011 | 14/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 17/06/2010 | 01/07/2010 | Dutch | |
| Abridged model | 31/12/2008 | 11/06/2009 | 13/06/2009 | Dutch | |
| Abridged model | 31/12/2007 | 12/06/2008 | 16/06/2008 | Dutch | |
| Abridged model | 31/12/2006 | 14/06/2007 | 03/07/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2025Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202569,8 k €↓
- 2024Annual accounts 2024110,7 k €↑
- 2023Annual accounts 202390,4 k €↓
- 2022Annual accounts 2022135,5 k €↑
- 2021Annual accounts 202125,8 k €↑
- 2020Annual accounts 202010,4 k €↑
- 2019Annual accounts 20191,3 k €↓
- 2018Annual accounts 201833,4 k €↓
- 2017Annual accounts 201747,7 k €↑
- 2016Annual accounts 2016-16,2 k €↑
- 2015Annual accounts 2015-46,2 k €↓
- 2014Annual accounts 2014-24,1 k €↓
- 2013Annual accounts 20136,3 k €↓
- 2012Annual accounts 201212,1 k €↑
- 2011Annual accounts 20116,4 k €↓
- 2010Annual accounts 201021,5 k €↑
- 2009Annual accounts 20092,6 k €↓
- 2008Annual accounts 20084,7 k €↓
- 2007Annual accounts 200719,4 k €↑
- 2006Annual accounts 2006-24,4 k €
- 28/12/1999IncorporationPrivate company with limited liability